1 Department of Radiology and Medical Imaging, University of Virginia, 1218 Lee St, Box 800170, Charlottesville, VA 22908.
2 University of Virginia Public Health Sciences, Charlottesville, VA.
AJR Am J Roentgenol. 2016 Nov;207(5):1055-1061. doi: 10.2214/AJR.15.15779. Epub 2016 Aug 30.
The purpose of this study was to determine whether intraarticular sacroiliac joint injections provide greater immediate and short-term pain relief than periarticular sacroiliac joint injections do.
The records of all fluoroscopically guided sacroiliac joint injections performed over a 4-year period were identified. Patients who received an injection of 0.5 mL of bupivacaine and 0.5 mL (20 mg) of triamcinolone and who had preinjection, immediate, and 1-week postinjection pain scores (0-10 numeric scale) were included. Images from the procedures were retrospectively reviewed by two musculoskeletal radiologists to determine intraarticular or periarticular administration of the injection with discrepancies resolved by consensus.
One hundred thirteen injections in 99 patients (65 women, 34 men; mean age, 59.4 years) met the inclusion criteria. There were 55 intraarticular and 58 periarticular injections. The mean preinjection, immediate, and 1-week postinjection pain scores for the intraarticular injections were 6.0, 1.6, and 4.1 and for the periarticular injections were 6.1, 2.0, and 4.2. The mean immediate and 1-week postinjection pain reduction were statistically significant in both groups (p < 0.001). After adjustment for age, sex, preinjection pain score, time of year, and indication for injection, no significant difference in the preinjection to immediately postinjection change in pain between intraarticular and periarticular injections (mean change, 0.37; p = 0.319) or in the preinjection to 1-week postinjection change in pain (mean change, 0.06; p = 0.888) was noted. The mean fluoroscopy times were 42.4 seconds for intraarticular injections and 60.5 seconds for periarticular injections (p = 0.32).
Although both intraarticular and periarticular sacroiliac joint injections provide statistically significant immediate and 1-week postinjection pain relief, no significant difference in the degree of pain relief achieved with intraarticular and periarticular injections was noted.
本研究旨在确定关节内骶髂关节注射是否比关节周围骶髂关节注射能提供更大的即刻和短期疼痛缓解。
确定了在 4 年期间进行的所有透视引导的骶髂关节注射的记录。纳入接受 0.5 mL 布比卡因和 0.5 mL(20 mg)曲安奈德注射且具有注射前、即刻和 1 周后疼痛评分(0-10 数字评分)的患者。通过两位肌肉骨骼放射科医生回顾性审查程序图像,以确定注射的关节内或关节周围给药,通过共识解决差异。
99 名患者(65 名女性,34 名男性;平均年龄 59.4 岁)的 113 次注射符合纳入标准。有 55 次关节内和 58 次关节周围注射。关节内注射的平均注射前、即刻和 1 周后疼痛评分为 6.0、1.6 和 4.1,关节周围注射的平均注射前、即刻和 1 周后疼痛评分为 6.1、2.0 和 4.2。两组的即刻和 1 周后疼痛缓解均具有统计学意义(p <0.001)。调整年龄、性别、注射前疼痛评分、一年中的时间和注射指征后,关节内和关节周围注射在注射前到即刻后疼痛变化之间或在注射前到 1 周后疼痛变化之间没有显著差异(平均变化,0.37;p = 0.319)。关节内注射的平均透视时间为 42.4 秒,关节周围注射为 60.5 秒(p = 0.32)。
尽管关节内和关节周围骶髂关节注射均能提供统计学上显著的即刻和 1 周后注射疼痛缓解,但关节内和关节周围注射的疼痛缓解程度没有显著差异。